The Metaverse is a Brand’s “Betterverse”

Justin Hochberg, CEO and Co-Founder of Virtual Brand Group, sums up his company’s mission in one easy sentence, “We put you in the Metaverse.” Hochberg joined Christine Russo to explain how Virtual Brand Group harnesses the power of web 3.0 for I.P. by creating consumer experiences to socialize, shop, make friends, and develop products in the virtual and physical world simultaneously.

Hochberg believes that the term Metaverse should not be synonymous with confusing. If Hochberg gets his way, people could soon think of the Metaverse as synonymous with a different word: opportunity.

“If you are a brand of any nature, from entertainment to sports, you now thought you had your business organized,” Hochberg said. “You were in E-comm, and you were in retail, and you did events at South by Southwest, and maybe you had a catalog, and you did social, and maybe if you were really advanced, you did live streaming. Today you wake up, and you’re like, wow, we thought we were an omnipresent brand, and all of a sudden, we are not because we are missing out on hundreds and hundreds of millions of consumers that are spending hundreds of hours a month on platforms like Roblox, Sandblox. Decentraland, etc.”

Virtual Brand Group brings companies into this brand-new world of the Metaverse. “We operate their businesses in the Metaverse,” Hochberg said. “We take all the operational risk by becoming a licensee of them and then building out their presence in first Roblox, or Sandbox. Then we operate a proprietary set of technology that allows us to create the assets once, and then spin them into any way we possibly can.”

One question remains whether the Metaverse will become an open or walled platform. Now, it appears as if there is room for both options. “The Metaverse is a series of technologies that people are using to build various experiences with different economic models,” Hochberg said. But while the opportunity door is open, brands should explore those options.

More Stories Like This:

Will It Be Possible to Create A Fully Autonomous Store?

The Future of eCcommerce Platforms in the Gaming Ecosystem

Follow us on social media for the latest updates in B2B!

Image

Latest

ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More
vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More